Life Technologies introduces first USDA-licensed real-time PCR test for detection of common disease in cattle

Top Quote Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science solutions,today introduced its first USDA-licensed real-time PCR test to detect bovine viral diarrhea virus (BVDV), a debilitating disease that costs the U.S. cattle industry an estimated $2 billion per year. End Quote
  • (1888PressRelease) December 02, 2010 - The Applied Biosystems VetMAX-Gold BVDV Detection Kit from Life Technologies provides veterinary diagnostic laboratories around the world with a sensitive tool to test cattle for type 1 and type 2 BVDV -- an immune-suppressing disease that makes cows susceptible to a range of respiratory and reproductive illnesses.

    "Due to the potential health and economic impact of the disease, it is important for producers to know with reasonable certainty if bovine viral diarrhea virus (BVDV) is circulating in their herd," said Brad White, DVM, MS, Associate Professor, Kansas State University, College of Veterinary Medicine. "The USDA licensing of the detection kit increases confidence when evaluating results. Accurate and reliable tests are critical when implementing strategies to control and eliminate BVDV from cattle herds."

    The approval of the VetMAX-Gold BVDV Detection Kit is based on the successful completion of the USDA's stringent review process to ensure safety and effectiveness of the real-time PCR test and evaluate production and quality systems compliance at the manufacturing site. Veterinary diagnosticians have historically relied on Life Technologies' molecular reagents and instrumentation to detect and control disease. However, the USDA-licensed product now provides them with a federally approved test containing all the necessary reagents and controls in a single kit.

    "We continue to see our PCR-based molecular biology tools gain acceptance in a growing number of applied market segments," said Peter Dansky, President of Molecular Biology Systems for Life Technologies. "The USDA's approval of our kit is a testament to Life Technologies' leadership as a supplier of highly accurate, reliable and cost-effective molecular tests that are having a positive impact on the cattle industry and other food producers."

    Life Technologies is committed to the animal health industry by offering leading products and services designed to help veterinary laboratory diagnosticians test for disease. The company's family of next generation molecular tools and easy-to-use instruments for PCR analysis provide the complete workflow that is needed to monitor the health of herd and flock animals worldwide.

    About Life Technologies (
    Life Technologies Corporation (NASDAQ:LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of $3.3 billion in 2009, employs approximately 9,000 people, has a presence in approximately 160 countries, and possesses a rapidly growing intellectual property estate of approximately 3,900 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc., and manufactures both in-vitro diagnostic products and research use only-labeled products. For more information on how we are making a difference, please visit our website:

    Life Technologies' Safe Harbor Statement
    This press release includes forward-looking statements about our anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies' plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense or conditional constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.

    Life Technologies
    Mauricio Minotta, 760-929-2456
    Mauricio.minotta ( @ ) lifetech dot com

  • FB Icon Twitter Icon In-Icon
Contact Information